Bradley Wiggins: corticosteroid use 'wasn't about trying to gain an unfair advantage'

Sir Bradley Wiggins asserts that his approved use of triamcinolone injections was not for performance-enhancing reasons, but to treat a long-term asthma problem

Bradley Wiggins on stage fourteen of the 2012 Tour de France

(Image credit: watson)

Bradley Wiggins, who came out in his defence of recent leaked TUE data this weekend, says that his corticosteroid use was not about trying to gain an unfair advantage in the Tour de France.

Russian hacker group Fancy Bears started leaking athletes' therapeutic use exemptions (TUEs) on its website two weeks ago. Wiggins and Sky's Chris Froome were part of a second data dump on the website. Wiggins's UCI-approved TUE showed he had permission to inject triamcinolone, a corticosteroid, prior to the 2011 and 2012 editions of the Tour, and the 2013 Giro d'Italia – his season's goals for those years.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Gregor Brown

Gregor Brown is an experienced cycling journalist, based in Florence, Italy. He has covered races all over the world for over a decade - following the Giro, Tour de France, and every major race since 2006. His love of cycling began with freestyle and BMX, before the 1998 Tour de France led him to a deep appreciation of the road racing season.